Insights into Dysregulated Neurological Biomarkers in Cancer

Area of Science:

• Biomedical Research
• Oncology
• Neuroscience

Background:

• Growing interest in the link between neurodegenerative diseases (NDs) and cancer.
• Identification of ND-associated proteins (e.g., Tau, amyloid-β, α-synuclein) in various cancers.
• Potential overlap in pathological mechanisms between NDs and malignancies.

Purpose of the Study:

• To review current evidence on the role of ND proteins in cancer.
• To examine their impact on tumor cell proliferation, apoptosis, chemoresistance, and progression.
• To discuss diagnostic and therapeutic implications and future research directions.

Main Methods:

• Literature review of studies investigating ND proteins in cancer.
• Analysis of evidence on protein involvement in cancer hallmarks.
• Exploration of diagnostic and therapeutic potential.

Main Results:

• ND-associated proteins are present in diverse solid tumors.
• These proteins influence key cancer processes like proliferation and chemoresistance.
• A significant overlap in pathological pathways is suggested.

Conclusions:

• The interconnection between ND proteins and cancer warrants further investigation.
• Targeting these proteins offers potential for novel anticancer therapies.
• Integrating ND knowledge into oncology research is crucial for clinical advancements.